No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Rival drugmakers Merck and Viatris have reached an agreement in their patent dispute over diabetes drugs Januvia and Janumet, pending approval from a judge. Attorneys for both companies…
Read More
USA — Novo Nordisk’s Ozempic, a treatment for type 2 diabetes and off-label for weight loss, is no longer on the FDA’s drug shortage list after months of limited supply.…
Read More
UNITED KINGDOM — Novo Nordisk has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years due to “serious breaches” of the trade…
Read More
USA — Sanofi has announced that it will reduce the list price of Lantus, its most widely prescribed insulin in the U.S., by 78% and cap monthly costs at US$35…
Read More
USA — Novo Nordisk has followed in the footsteps of Eli Lilly by announcing a reduction in the prices of its insulin products in the United States two weeks after…
Read More
NETHERLANDS — The European Medicines Agency (EMA) has urged doctors to prioritize the diabetes drug Ozempic, manufactured by Novo Nordisk, for patients with diabetes who may be at risk if…
Read More
FRANCE — French drugmaker Sanofi has agreed to acquire US-based pharmaceutical firm Provention Bio for approximately US$2.9 billion to strengthen its general medicines portfolio with the US-approved type 1 diabetes…
Read More
USA — Senator Bernie Sanders, Chair of the Senate Health Committee, has introduced a new bill alongside a companion bill in the House that aims to set the price of…
Read More
USA — Eli Lilly is set to reduce insulin prices and expand cost cap for insured patients, offering relief to those with diabetes who have to pay high annual costs…
Read More
EGYPT – Astellas Pharma Inc. launched a novel treatment indicated for adult patients in Egypt with anemia associated with chronic kidney disease (CKD). According to the company statement, chronic kidney…
Read More